An experimental study of editable DNA nanoflowers inhibiting the proliferation,migration and invasion of Lewis lung carcinoma cells

Cao Yuchao, Liao Hongjian, Hu Can, Guo Jiajun, Du Yonghong

PDF(4964 KB)
PDF(4964 KB)
Journal of Chongqing Medical University ›› 2024, Vol. 49 ›› Issue (09) : 1105-1112. DOI: 10.13406/j.cnki.cyxb.003578
Basic research

An experimental study of editable DNA nanoflowers inhibiting the proliferation,migration and invasion of Lewis lung carcinoma cells

Author information +
History +

Abstract

Objective To investigate the effects on the proliferation,migration and invasion of Lewis lung carcinoma(LLC) cells induced by DNA nanoflowers(DFs) carrying doxorubicin(DOX) and hypoxia inducible factor-1α(HIF-1α) antisense oligonucleotides. Methods DFs containing HIF-1α antisense oligonucleotides(DHA-DF) were synthesized by rolling circle amplification,and the physical properties of DHA-DF were examined. DOX was loaded into DFs to form DDF.We evaluated the cell viability of LLC cells treated with DHA-DDF by using Cell Counting Kit-8; assessed the effects of DHA-DDF on the migration and invasion of LLC cells by using scratch assay and Transwell assay; and measured the expression level of HIF-1α in LLC cells by Western blot and quantitative polymerase chain reaction. Results DHA-DF appeared flower-like porous spherical particles with a size of (421.26±7.90) nm. Compare with free DOX and DA-DDF,DHA-DDF significantly decreased the mRNA and protein expression of HIF-1α in LLC cells,and significantly reduced cell viability,the area of wound healed and the number of invasive cells(all P<0.05). Conclusion DHA-DDF could effectively reduce the expression of HIF-1α,and inhibit the proliferation,migration and invasion of LLC cells,providing new ideas for clinical treatment of tumors.

Key words

DNA nanoflower / hypoxia / lung cancer / antisense oligonucleotide

Cite this article

Download Citations
Cao Yuchao , Liao Hongjian , Hu Can , et al . An experimental study of editable DNA nanoflowers inhibiting the proliferation,migration and invasion of Lewis lung carcinoma cells. Journal of Chongqing Medical University. 2024, 49(09): 1105-1112 https://doi.org/10.13406/j.cnki.cyxb.003578

References

1
Huang XL Zhuang J Chung SW,et al. Hypoxia-tropic protein nanocages for modulation of tumor- and chemotherapy-associated hypoxia[J]. ACS Nano201913(1):236-247.
2
Li ML Xia J Tian RS,et al. Near-infrared light-initiated molecular superoxide radical generator:rejuvenating photodynamic therapy against hypoxic tumors[J]. J Am Chem Soc2018140(44):14851-14859.
3
Chen J Luo HL Liu Y,et al. Oxygen-self-produced nanoplatform for relieving hypoxia and breaking resistance to sonodynamic treatment of pancreatic cancer[J]. ACS Nano201711(12):12849-12862.
4
Park JH Moon M Kim JS,et al. TOPK mediates hypoxia-induced epithelial-mesenchymal transition and the invasion of nonsmall-cell lung cancer cells via the HIF-1α/snail axis[J]. Biochem Biophys Res Commun2021534:941-949.
5
Vito A El-Sayes N Mossman K. Hypoxia-driven immune escape in the tumor microenvironment[J]. Cells20209(4):992.
6
Wu QH You L Nepovimova E,et al. Hypoxia-inducible factors:master regulators of hypoxic tumor immune escape[J]. J Hematol Oncol202215(1):77.
7
Wang K Zhu X Zhang K,et al. Interleukin-6 contributes to chemoresistance in MDA-MB-231 cells via targeting HIF-1α[J]. J Biochem Mol Toxicol201832(3):e22039.
8
Li H Quan JS Zhang MZ,et al. Lipid-albumin nanoparticles(LAN) for therapeutic delivery of antisense oligonucleotide against HIF-1α[J]. Mol Pharm201613(7):2555-2562.
9
Pan M Jiang QY Sun JL,et al. Programming DNA nanoassembly for enhanced photodynamic therapy[J]. Angew Chem Int Ed202059(5):1897-1905.
10
Crooke ST Baker BF Crooke RM,et al. Antisense technology:an overview and prospectus[J]. Nat Rev Drug Discov202120(6):427-453.
11
Bennett CF Baker BF Pham N,et al. Pharmacology of antisense drugs[J]. Annu Rev Pharmacol Toxicol201757:81-105.
12
Mei L Zhu GZ Qiu LP,et al. Self-assembled multifunctional DNA nanoflowers for the circumvention of multidrug resistance in targeted anticancer drug delivery[J]. Nano Res20158(11):3447-3460.
13
Kuerban K Gao XW Zhang H,et al. Doxorubicin-loaded bacterial outer-membrane vesicles exert enhanced anti-tumor efficacy in non-small-cell lung cancer[J]. Acta Pharm Sin B202010(8):1534-1548.
14
Dai ZD Song XZ Cao JK,et al. Dual-stimuli-responsive TiO x /DOX nanodrug system for lung cancer synergistic therapy[J]. RSC Adv20188(39):21975-21984.
15
Bhatia SN Chen XY Dobrovolskaia MA,et al. Cancer nanomedicine[J]. Nat Rev Cancer202222(10):550-556.
16
Rizvi SAA Saleh AM. Applications of nanoparticle systems in drug delivery technology[J]. Saudi Pharm J201826(1):64-70.
17
Bie LH Wang Y Jiang FZ,et al. Insights into the binding mode of AS1411 aptamer to nucleolin[J]. Front Mol Biosci20229:1025313.
18
Gao YT Zhou H Liu GG,et al. Tumor microenvironment:lactic acid promotes tumor development[J]. J Immunol Res20222022:3119375.
19
Keizer HG Pinedo HM Schuurhuis GJ,et al. Doxorubicin(adriamycin):a critical review of free radical-dependent mechanisms of cytotoxicity[J]. Pharmacol Ther199047(2):219-231.
20
He YX Liu SH Yin J,et al. Sonodynamic and chemodynamic therapy based on organic/organometallic sensitizers[J]. Coord Chem Rev2021429:213610.
21
Cheng JJ Zhu Y Xing X,et al. Manganese-deposited iron oxide promotes tumor-responsive ferroptosis that synergizes the apoptosis of cisplatin[J]. Theranostics202111(11):5418-5429.
22
Li L Chen YS Chen WJ,et al. Photodynamic therapy based on organic small molecular fluorescent dyes[J]. Chin Chem Lett201930(10):1689-1703.

Comments

PDF(4964 KB)

Accesses

Citation

Detail

Sections
Recommended

/